Leitlinie „Behandlung der Akne“ - AWMF

013/017 - Behandlung der Akne aktueller Stand: 02/2010
korrigierte Fassung: 10/2011
147. Plewig G, Holland KT, Nenoff P. Clinical and bacteriological evaluation of
nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III
comparison study versus erythromycin 2% cream. Eur J Dermatol. 2006; 16: 48-55.
148. Anderson RL, Cook CH, Smith DE. The effect of oral and topical tetracycline on acne
severity and on surface lipid composition. J Invest Dermatol. 1976; 66: 172-7.
149. Blaney DJ, Cook CH. Topical use of tetracycline in the treatment of acne: a doubleblind
study comparing topical and oral tetracycline therapy and placebo. Arch
Dermatol. 1976; 112: 971-3.
150. Toyoda M, Morohashi M. An overview of topical antibiotics for acne treatment.
Dermatology. 1998; 196: 130-4.
151. Panzer JD, Poche W, Meek TJ, Derbes VJ, Atkinson W. Acne treatment: a
comparative efficacy trial of clindamycin and tetracycline. Cutis. 1977; 19: 109-11.
152. Langner A, Chu A, Goulden V, Ambroziak M. A randomized, single-blind
comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment
of mild to moderate facial acne vulgaris. Br J Dermatol. 2008; 158: 122-9.
153. Zouboulis CC, Fischer TC, Wohlrab J, Barnard J, Alio AB. Study of the efficacy,
tolerability, and safety of 2 fixed-dose combination gels in the management of acne
vulgaris. Cutis. 2009; 84: 223-9.
154. Hegemann L, Toso SM, Kitay K, Webster GF. Anti-inflammatory actions of benzoyl
peroxide: effects on the generation of reactive oxygen species by leucocytes and the
activity of protein kinase C and calmodulin. Br J Dermatol. 1994; 130: 569-75.
155. Thiele JJ. Oxidative targets in the stratum corneum. A new basis for antioxidative
strategies. Skin Pharmacol Appl Skin Physiol. 2001; 14 Suppl 1: 87-91.
156. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based
medicine: How to practice and teach EBM. London: Churchill Livingstone, 2001:
169-82.
157. Smith EB, Padilla RS, McCabe JM, Becker LE. Benzoyl peroxide lotion (20 percent)
in acne. Cutis. 1980; 25: 90-2.
158. Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Po AL, O'Neill C, Simpson NB,
Walters CE, Carnegie E, Lewis JB, Dada J, Haynes M, Williams K, Williams HC.
Comparison of five antimicrobial regimens for treatment of mild to moderate
inflammatory facial acne vulgaris in the community: randomised controlled trial.
Lancet. 2004; 364: 2188-95.
159. Mills OH, Jr., Kligman AM, Pochi P, Comite H. Comparing 2.5%, 5%, and 10%
benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol. 1986; 25: 664-7.
160. Thiboutot D, Zaenglein A, Weiss J, Webster G, Calvarese B, Chen D. An aqueous gel
fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the
once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and
safety in 2813 patients. J Am Acad Dermatol. 2008; 59: 792-800.
161. Cunliffe WJ, Burke B. Benzoyl peroxide: lack of sensitization. Acta Derm Venereol.
1982; 62: 458-9.
162. Jeanmougin M, Pedreiro J, Bouchet J, Civatte J. [Phototoxic activity of 5% benzoyl
peroxide in man. Use of a new methodology]. Dermatologica. 1983; 167: 19-23.
Seite 115 von 136